President’s address: Clinical research on Breast Cancer at the aichi cancer center: Past, present, and future of hormone therapy Shigeto Miura Announcement Pages: 264 - 269
Molecular pathology of Breast Cancer: Prognostic and predictive markers in this century and the next Diana M. Barnes OriginalPaper Pages: 275 - 282
Epidemiology and prevention of Breast Cancer in the 21 st century Suketami TominagaTetsuo Kuroishi OriginalPaper Pages: 283 - 288
Sentinel node biopsy in breast cancer Kazuyoshi MotomuraHideo InajiHiroki Koyama OriginalPaper Pages: 289 - 291
New treatment strategy for bone metastases from breast cancer Norio KohnoSohei KitazawaKatunori Kawaguti OriginalPaper Pages: 292 - 297
Significance of steroid sulfatase expression in human breast cancer Toshiaki UtsumiNoriko YoshimuraNobuhiro Harada OriginalPaper Pages: 298 - 300
Adenoviral GM-CSF gene transduction into breast cancer cells induced long-lasting antitumor immunity in mice Takahiro OgawaMasahiro KusumotoMasao Tanaka OriginalPaper Pages: 301 - 304
Identification of cancer antigens in breast cancer by the SEREX expression cloning method Yuichi ObataToshitada TakahashiShigeto Miura OriginalPaper Pages: 305 - 311
Relevance of ER to the development of endometrial hyperplasia and adenocarcinoma Kiyoko KatoShinji HoriuchiNorio Wake OriginalPaper Pages: 312 - 319
Hormone refractory prostate cancer and fibroblast growth factor receptor Akio MatsubaraHiroaki YasumotoTsuguru Usui OriginalPaper Pages: 320 - 324
Clinical significance of estrogen receptor β in breast cancer Hirotaka IwaseYoko OmotoShunzo Kobayashi OriginalPaper Pages: 325 - 330
Localization of estrone sulfatase in human breast carcinomas Toshiaki SaekiShigemitsu TakashimaDavid S. Salomon OriginalPaper Pages: 331 - 337
The shbg gene and hormone dependence of Breast Cancer: A novel mechanism of hormone dependence of MCF-7 human breast cancer cells based upon SHBG Yoichi MurayamaGeoffrey L. HammondKenichi Sugihara OriginalPaper Pages: 338 - 343
Current status and controversial issues concerning endocrine therapy for patients with recurrent breast cancer in Japan Hiroshi SonooJunichi KurebayashiMasataka Yoshimoto OriginalPaper Pages: 344 - 350
Correlation of allelic loss with poor postoperative survival in breast cancer Mitsuru EmiYoshihito UtadaYusuke Nakamura OriginalPaper Pages: 351 - 356
Prognostic significance of the urokinase type plasminogen activator (u-PA) system in node-negative breast cancer Eiichi ShibaSeung Jin KimShinzaburo Noguchi OriginalPaper Pages: 357 - 360
Plasma nucleosome levels in node-negative breast cancer patients Katsumasa KuroiChikako TanakaMasakazu Toi OriginalPaper Pages: 361 - 364
Maximum density of tumor staining obtained by preoperative IV-DSA as a prognostic indicator for node-negative breast cancer Osamu WatanabeShunsuke HagaTetsuro Kajiwara OriginalPaper Pages: 365 - 369
New prognostic factors associated with long-term survival in node-negative breast cancer patients Takao KatoTsunehito KimuraTakeshi Kasajima OriginalPaper Pages: 370 - 377
New systemic therapy for breast cancer Pierre FumoleauDominique Berton-RigaudStephanie Bordenave OriginalPaper Pages: 382 - 385
Intensive adjuvant chemotherapy for breast cancer Robert C. F. Leonard OriginalPaper Pages: 386 - 390
